Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Dividend Payout Ratio: 4.14 (As of Mar. 2026) — 935% Above Median

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SHSE:600329

65 GF Score

Price ¥36.28

GF Value ¥23.63

Valuation Significantly Overvalued

5 Warning Signs

View Full Analysis

What is Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio?

Tianjin Pharmaceutical Da Ren Tang Group SHSE:600329 -1.89% 65 Dividend Payout Ratio is 4.14 as of Mar. 2026, which is 935% above its 10-year median of 0.40. GuruFocus rates SHSE:600329 with a GF Score™ of 65/100 and a GF Value™ of ¥23.63 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 444 Drug Manufacturers companies, Tianjin Pharmaceutical Da Ren Tang Group ranks worse than 93.69% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the months ended in Mar. 2026 was 4.14.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 1.24, which seems too high.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio or its related term are showing as below:

SHSE:600329' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.28 Med: 0.4 Max: 1.32
Current: 1.24

During the past 13 years, the highest Dividend Payout Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 1.32. The lowest was 0.28. And the median was 0.40.

SHSE:600329's Dividend Payout Ratio is ranked worse than
93.69% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs SHSE:600329: 1.24

As of today (2026-07-28), the Dividend Yield % of Tianjin Pharmaceutical Da Ren Tang Group is 13.20%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Tianjin Pharmaceutical Da Ren Tang Group was 13.22%. The lowest was 0.70%. And the median was 1.56%.

Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share for the months ended in Mar. 2026 was ¥2.45.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Dividends Per Share Growth Rate was 191.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 36.80% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 42.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 26.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 62.20% per year. The lowest was -37.00% per year. And the median was 20.25% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Related Terms

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividend Payout Ratio

Get a 7-Day Free Trial

0.31

0.43

0.91

1.32

1.24

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividend Payout Ratio	Get a 7-Day Free Trial															0.00	0.64	0.00	0.00	4.14

SHSE:600329 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio falls into.

Save Embed

65GF Score

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd SHSE:600329

Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Calculation

Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2025 )	/	EPS without NRI (A: Dec. 2025 )
	=	1.28	/	1.03
	=	1.24

Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	2.45	/	0.592
	=	4.14

Frequently Asked Questions Learn more about Dividend Payout Ratio →

What does a Dividend Payout Ratio of 4.14 mean?

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) has a Dividend Payout Ratio of 4.14 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors. This is 935% above median its historical median of 0.40. Over the past decade, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio has ranged from 0.28 to 1.32. According to the industry distribution chart, Tianjin Pharmaceutical Da Ren Tang Group ranks #416 out of 444 companies in the Drug Manufacturers industry, placing it in the top 93.7%.

Is Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio too high?

Tianjin Pharmaceutical Da Ren Tang Group's current Dividend Payout Ratio of 4.14 is 935% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 1.32. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Tianjin Pharmaceutical Da Ren Tang Group's value of 4.14 is 989.5% above this industry median. Based on the distribution chart, Tianjin Pharmaceutical Da Ren Tang Group ranks #416 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tianjin Pharmaceutical Da Ren Tang Group has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio compare to ZTS?

According to the Drug Manufacturers industry distribution chart, Tianjin Pharmaceutical Da Ren Tang Group ranks #416 out of 444 companies for Dividend Payout Ratio. This places Tianjin Pharmaceutical Da Ren Tang Group in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Tianjin Pharmaceutical Da Ren Tang Group's value of 4.14 is 989.5% above this benchmark. Historically, Tianjin Pharmaceutical Da Ren Tang Group's own Dividend Payout Ratio has ranged from 0.28 to 1.32 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.38, Tianjin Pharmaceutical Da Ren Tang Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividend Payout Ratio for a Drug Manufacturers company?

The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tianjin Pharmaceutical Da Ren Tang Group's current Dividend Payout Ratio of 4.14 is 989.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividend Payout Ratio mean?

A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tianjin Pharmaceutical Da Ren Tang Group's current Dividend Payout Ratio is 4.14, which is 935% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Tianjin Pharmaceutical Da Ren Tang Group stock overvalued right now?

Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥23.63, compared to a current price of ¥36.28 — trading 53.5% above its estimated fair value. The current Dividend Payout Ratio is 4.14, which is 935% above median its 10-year median of 0.40 and 989.5% above the Drug Manufacturers industry median of 0.38. Tianjin Pharmaceutical Da Ren Tang Group's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividend Payout Ratio calculated?

Dividend Payout Ratio is calculated from a company's financial statements. For Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329), the current Dividend Payout Ratio is 4.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group stock appears to be overvalued. The current stock price of ¥36.28 is trading 53.5% above its estimated GF Value™ of ¥23.63. GuruFocus considers Tianjin Pharmaceutical Da Ren Tang Group to be Significantly Overvalued.

Key valuation signals for SHSE:600329:

Dividend Payout Ratio: 4.14 (935% above median its 10-year median of 0.40)
GF Value™: ¥23.63 vs. price of ¥36.28 (53.5% above fair value)
GF Score™: 65/100 with 5 warning signs
Industry Position: 989.5% above the Drug Manufacturers median (#416 of 444)

No single metric tells the full story. See the SHSE:600329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tianjin Pharmaceutical Da Ren Tang Group Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies SHSE:600566 SZSE:300558 SZSE:000513 SHSE:600521 SHSE:600535 SHSE:688192 SZSE:000739 SZSE:002317 SZSE:002603 SZSE:002262 XTER:MRK TSE:4502 SHSE:600276 XSWX:GALD NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS HKSE:03692

Other Exchanges T14:Singapore 2TZ:Germany

Address No. 17 Baidi Road, Darentang Building, Nankai District, Tianjin, CHN, 300193

Website https://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company is engaged in the production and sale of traditional Chinese medicine, Western medicine, healthcare products, and investment holding. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese medicine.

65GF Score

Get the complete analysis for SHSE:600329

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥36.28

Price

¥23.63

GF Value

View SHSE:600329 Analysis

See Dividend Payout Ratio data for all stocks →